Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DeltaNp63 expression is associated with poor survival in ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Mar 2008

Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Fruscio R, Lissoni A A, Broggini M

Abstract excerpt

BACKGROUND: P63 belongs to the 'p53 family' whose role in cancer progression has been recently revisited in light of the plethora of splicing variants that are generated. We analyzed the expression of the full-length TAp63 gene and its dominant-negative form deltaNp63 in ovarian cancer biopsies to correlate their expression with clinical outcome. MATERIALS AND METHODS: Real-time RT-PCR analysis was used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Survival Analysis

Share to Trans-Activators

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 17998283
DOI: 10.1093/annonc/mdm519

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DeltaNp63 expression is associated with poor survival in ovarian cancer.PMID 17998283Read ↗

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancersSemantic proximity Read ↗

p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.Semantic proximity Read ↗

A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissuesSemantic proximity Read ↗

Frequent alteration of p63 expression in human primary bladder carcinomas.Semantic proximity Read ↗

TP63 isoform expression is linked with distinct clinical outcomes in cancerSemantic proximity Read ↗

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.Semantic proximity Read ↗

p63-related signaling at a glanceSemantic proximity Read ↗

Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.Semantic proximity Read ↗

The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.Semantic proximity Read ↗

TAp63 and DeltaNp63 in cancer and epidermal development.Semantic proximity Read ↗

The p53-homologue p63 may promote thyroid cancer progression.Semantic proximity Read ↗

Isoform-specific cofactor recruitment through the intrinsically disordered N-terminus of p63 underlies differential transcriptional activitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.